Axol Bioscience appoints Liam Taylor as Chief Executive Officer

New CEO to steer the next stage of Axol Bioscience’s growth in the global iPSC stem cell markets Cambridge, UK, 27 August 2020: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to...

Arctoris and Syntekabio Form Research Partnership

Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of Understanding with listed Korean company Syntekabio, Inc. to collaborate on drug discovery efforts. The first project under...

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Next Generation ADC Uses Proprietary Technologies Aimed at Enhancing Cancer Therapy Efficacy and Safety Nijmegen, The Netherlands – 11 August 2020 – Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients...

LAUDA Technology Ltd.

LAUDA is advancing the connectivity of temperature control technology with the new Integral process thermostats. Thanks to the modular interface concept and intuitive operation via the integrated web server, they are more user-friendly and...

UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S....

London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company,...

Opening new pathways for bioprocessing

A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives. One is to drive research into bioprocessing, an often-overlooked subject through which life...

Firms call for major R&I investment to tackle environmental crises

Major investment into research and innovation (R&I) is needed to enable UK businesses to address the global biodiversity and climate crises, according to a new report. The report by the Valuing Nature Programme --– which...

Discovery raises possibility of asthma treatment

A University of Dundee researcher has uncovered why parasitic worm infections seem to protect people from developing asthma, paving the way for potential future treatments for the disease. Although it has been known for some...

Nemera takes dermal treatments to millions of patients

Nemera is a world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, including complex dermal drug delivery devices. Dermal pharmaceuticals, cosmetics and personal hygiene products all...

Find out why County Durham’s NETPark is quickly becoming a global hub for bio-science...

Home to two UK catapult centres, three national innovation centres and one of the country’s leading AIM listed tech companies, The North East Technology Park (NETPark) really is a thriving hub of innovation making...

BIOQUELL HELPING PHARMACEUTICAL COMPANIES RESUME OPERATIONS POST-COVID-19

Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity As the world prepares to enter the next phase of the COVID-19 pandemic with the potential...

anti-cancer compound discovered in the humble willow

Scientists led from Rothamsted Research, working with cancer biologists at the University of Kent have discovered the chemical, miyabeacin, which has been found to kill various cancer cells, including those resistant to other drugs. Of...

Switching on a key gene could provide first curative treatment for heart disease

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell...

Sellafield research uncovers microbial life in fuel ponds

Two new research papers from The University of Manchester, working with colleagues at Sellafield Limited and the National Nuclear Laboratory show that microbes can actively colonise some of the most intensively radioactive waste storage...

Directing’ evolution to identify potential drugs earlier in discovery

Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease. Antibodies are produced by the body in response to the presence of a disease-causing agent....

Nemera and Noble announce collaboration to support patients who self-administer medication

 Nemera is excited to leverage the new collaboration to expand end-to-end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices  Nemera, world leader in design, development and manufacturing of drug...